Drug profile · INN
nirogacestat
OGSIVEO
nirogacestat (OGSIVEO) is a gamma-secretase inhibitor.
EMA: approved Antineoplastic and immunomodulating agents (L01) L01XX81
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — nirogacestat
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
nirogacestat (OGSIVEO) is a gamma-secretase inhibitor.
Key facts
INN nirogacestat
Brand OGSIVEO
Mechanism Gamma-secretase inhibitor
Target Gamma-secretase
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01XX81
Mechanism of action
Gamma-secretase inhibitor
Primary target: Gamma-secretase
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is nirogacestat?
nirogacestat (OGSIVEO) is a gamma-secretase inhibitor.
What is the brand name for nirogacestat?
OGSIVEO is a marketed brand name for nirogacestat. Check FDA Drugs@FDA for the current US label holder and prescribing information.